If you liked this article you might like

Jim Cramer: AstraZeneca Is Reinventing Itself in Anti-Cancer
AstraZeneca Is Now a Competitive Threat to Tesaro in Ovarian Cancer Maintenance Therapy
Analysts' Actions -- Ameriprise, ConAgra, Domino's, Lear and More
Even High-Flying Tesaro and Its Ovarian Cancer Drug Has a Bear Thesis. Here It Is, Explained